Skip to main content

Table 1 Clinical features, treatment histories, and survival data

From: Molecular profiling of pre- and post-treatment pediatric high-grade astrocytomas reveals acquired increased tumor mutation burden in a subset of recurrences

Case

Age (years)

Sex

Tumor location

Resection

Tumor type at diagnosis or per WHO CNS 5

Chemoradiation

Maintenance Temozolomide

TMZ end to recurrence (days)

Overall survival and (survival from recurrence)

pTMZ-01

14

M

Left temporal

Biopsy

Infiltrating anaplastic astrocytoma with areas of PNET-like dedifferentiation

5940 cGy

TMZ 90 mg/m2 daily for 42 days

10 cycles

150–200 mg/m2 daily for 5 days

114

814 (245)

pTMZ-02

16

M

Left parietal

Gross total

Anaplastic oligoastrocytoma

5940 cGy

TMZ 90 mg/m2 daily for 42 days

15 cycles 200 mg/m2 daily for 5 days

2306

3584 (740)

pTMZ-03

12

M

Right frontotemporal

Gross total

Diffuse pediatric-type high-grade glioma, H3/IDH-wildtype

6000 cGy

TMZ 90 mg/m2 daily for 42 days

17 cycles 150 mg/m2 daily for 5 days

0 [progressed on maintenance therapy]

1044 (406)

pTMZ-04

12

F

Right frontal

Gross total

Diffuse pediatric-type high-grade glioma, H3/IDH-wildtype

6000 cGy

TMZ 160 mg daily for 42 days

18 cycles 200 mg/m2 daily for 5 days

905

1839 (293)

pTMZ-05

6

M

Right cingulate

Gross total

Anaplastic astrocytoma

5940 cGy

TMZ 90 mg/m2 daily for 42 days

18 cycles 90 mg/m2 daily for 5 days

744

1639 (255)

pTMZ-06

11

M

Right frontotemporal

Biopsy

Anaplastic astrocytoma

Radiation details not available

TMZ 100 mg daily for 42 days

1300 mg/cycle

Number of cycles not available

397

892 (132)

pTMZ-07

16

F

Left frontal

Gross total

Diffuse hemispheric glioma, H3 G34-mutant

6000 cGy

TMZ 90 mg/m2 daily for 42 days

18 cycles

200 mg/m2 daily for 5 days

473

1433 (376)

pTMZ-08

13

M

Pineal region

Gross total

Atypical mixed glioneuronal neoplasm with aggressive features, arising in a background of papillary glioneuronal tumor

5940 cGy

TMZ 90 mg/m2 daily for 21 days

3 cycles

200 mg/m2 daily for 5 days

0 [progressed on maintenance therapy]

473 (275)

pTMZ-09

8

M

Right temporal

Subtotal

Glioblastoma

Chemoradiation details not available

12 cycles

1300 mg/cycle

183

1086 (419)

pTMZ-10

11

M

Right temporal

Gross total

Anaplastic astrocytoma

5940 cGy

TMZ 120 mg daily for 28 days

None

315

728 (657)

pTMZ-11

17

F

Right cerebellum

Subtotal

Astrocytoma, IDH-mutant, CNS WHO grade 4

5940 cGy

TMZ 160 mg daily for 41 days

Maintenance details not available

894

2094 (628)